JNJ
Price
$176.97
Change
-$1.16 (-0.65%)
Updated
Sep 9, 04:59 PM (EDT)
Capitalization
426.18B
34 days until earnings call
PFE
Price
$24.72
Change
+$0.17 (+0.69%)
Updated
Sep 9, 04:59 PM (EDT)
Capitalization
140.49B
55 days until earnings call
Interact to see
Advertisement

JNJ vs PFE

Header iconJNJ vs PFE Comparison
Open Charts JNJ vs PFEBanner chart's image
Johnson & Johnson
Price$176.97
Change-$1.16 (-0.65%)
Volume$61.73K
Capitalization426.18B
Pfizer
Price$24.72
Change+$0.17 (+0.69%)
Volume$419.24K
Capitalization140.49B
JNJ vs PFE Comparison Chart in %
Loading...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JNJ vs. PFE commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JNJ is a StrongBuy and PFE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 10, 2025
Stock price -- (JNJ: $176.96 vs. PFE: $24.71)
Brand notoriety: JNJ and PFE are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: JNJ: 71% vs. PFE: 79%
Market capitalization -- JNJ: $426.18B vs. PFE: $140.49B
JNJ [@Pharmaceuticals: Major] is valued at $426.18B. PFE’s [@Pharmaceuticals: Major] market capitalization is $140.49B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $672.89B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JNJ’s FA Score shows that 4 FA rating(s) are green whilePFE’s FA Score has 1 green FA rating(s).

  • JNJ’s FA Score: 4 green, 1 red.
  • PFE’s FA Score: 1 green, 4 red.
According to our system of comparison, JNJ is a better buy in the long-term than PFE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JNJ’s TA Score shows that 2 TA indicator(s) are bullish while PFE’s TA Score has 4 bullish TA indicator(s).

  • JNJ’s TA Score: 2 bullish, 4 bearish.
  • PFE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than PFE.

Price Growth

JNJ (@Pharmaceuticals: Major) experienced а -0.62% price change this week, while PFE (@Pharmaceuticals: Major) price change was -1.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.10%. For the same industry, the average monthly price growth was +4.65%, and the average quarterly price growth was +13.54%.

Reported Earning Dates

JNJ is expected to report earnings on Oct 14, 2025.

PFE is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+1.10% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($426B) has a higher market cap than PFE($140B). JNJ has higher P/E ratio than PFE: JNJ (18.95) vs PFE (13.07). JNJ YTD gains are higher at: 25.312 vs. PFE (-1.849). JNJ has higher annual earnings (EBITDA): 35.6B vs. PFE (20.2B). JNJ has more cash in the bank: 18.9B vs. PFE (13.2B). JNJ has less debt than PFE: JNJ (50.8B) vs PFE (60.9B). JNJ has higher revenues than PFE: JNJ (90.6B) vs PFE (63.8B).
JNJPFEJNJ / PFE
Capitalization426B140B304%
EBITDA35.6B20.2B176%
Gain YTD25.312-1.849-1,369%
P/E Ratio18.9513.07145%
Revenue90.6B63.8B142%
Total Cash18.9B13.2B143%
Total Debt50.8B60.9B83%
FUNDAMENTALS RATINGS
JNJ vs PFE: Fundamental Ratings
JNJ
PFE
OUTLOOK RATING
1..100
7716
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
3262
PRICE GROWTH RATING
1..100
3155
P/E GROWTH RATING
1..100
8198
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PFE's Valuation (5) in the Pharmaceuticals Major industry is in the same range as JNJ (16). This means that PFE’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (27) in the Pharmaceuticals Major industry is significantly better than the same rating for PFE (100). This means that JNJ’s stock grew significantly faster than PFE’s over the last 12 months.

JNJ's SMR Rating (32) in the Pharmaceuticals Major industry is in the same range as PFE (62). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's Price Growth Rating (31) in the Pharmaceuticals Major industry is in the same range as PFE (55). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

JNJ's P/E Growth Rating (81) in the Pharmaceuticals Major industry is in the same range as PFE (98). This means that JNJ’s stock grew similarly to PFE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
JNJPFE
RSI
ODDS (%)
Bearish Trend 2 days ago
22%
Bearish Trend 2 days ago
47%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
43%
Bullish Trend 2 days ago
49%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
33%
Bearish Trend 2 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
42%
Bearish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 8 days ago
42%
Bullish Trend 8 days ago
57%
Declines
ODDS (%)
Bearish Trend 2 days ago
43%
Bearish Trend 6 days ago
59%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
43%
Bullish Trend 2 days ago
53%
View a ticker or compare two or three
Interact to see
Advertisement
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PFE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IUSG159.950.64
+0.40%
iShares Core S&P US Growth ETF
NMB25.050.03
+0.12%
Simplify National Muni Bond ETF
DLY15.65N/A
N/A
DoubleLine Yield Opportunities Fund
MOTI37.30-0.01
-0.02%
VanEck Morningstar Intl Moat ETF
AVMA64.34-0.06
-0.10%
Avantis Moderate Allocation ETF

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.66%
PFE - JNJ
59%
Loosely correlated
+0.65%
NVS - JNJ
54%
Loosely correlated
-0.51%
GSK - JNJ
48%
Loosely correlated
+1.82%
BIIB - JNJ
44%
Loosely correlated
+1.59%
SNY - JNJ
43%
Loosely correlated
+1.39%
More

PFE and

Correlation & Price change

A.I.dvisor indicates that over the last year, PFE has been loosely correlated with GSK. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PFE
1D Price
Change %
PFE100%
+0.65%
GSK - PFE
57%
Loosely correlated
+1.82%
NVS - PFE
57%
Loosely correlated
-0.51%
BIIB - PFE
56%
Loosely correlated
+1.59%
ABBV - PFE
53%
Loosely correlated
+0.30%
BMY - PFE
53%
Loosely correlated
+1.09%
More